Skip to main content
. 2021 Oct 16;158:106930. doi: 10.1016/j.envint.2021.106930

Table 1.

Demography, anthropometry, clinical characteristics and long-term exposure to NO2 and PM10 of the population included in the study.

Pius Hospital de Valls Hospital Verge de la Cinta (Tortosa) Hospital Universitari Sant Joan
(Reus)
Hospital Universitari Joan XXIII

Hospital Sant Pau i Santa Tecla
(Tarragona)
Hospital del Vendrell Hospital Santa Creu Sant Pau
Hospital Universitari Vall d’Hebron
Hospital del Mar
Hospital HM Delfos
(Barcelona)
Hospital de Santa Caterina (Girona) Althaia
(Manresa)
Hospital Comarcal de Blanes Consorci Sanitari de Terrassa Hospital Moises Broggi
(Sant Joan Despí)
N 81 62 143 172 112 572 220 248 100 302 100
Sex (female) 28 (34.6%) 27 (43.5%) 57 (39.9%) 58 (33.7%) 47 (42.0%) 282 (49.3%) 76 (34.5%) 102
(41.1%)
42 (42.0%) 153 (50.7%) 34 (34.0%)
Age 64.0 [51.0;76.0] 69.0 [57.0;75.8] 64.0 [55.0;77.0] 70.0 [57.0;78.2] 72.0 [56.8;82.0] 65.5 [53.0;79.0] 66.0 [53.0;81.0] 72.0 [61.0;80.0] 62.0 [53.8;74.2] 70.0 [59.0;80.0] 50.5 [43.0;56.2]
Smoker 4 (14.8%) 2 (3.39%) 6 (4.65%) 7 (4.27%) 7 (7.37%) 32 (5.68%) 16 (7.66%) 12 (4.84%) 6 (6.59%) 8 (2.68%) 5 (5.00%)
Personal history of diseases
High Blood Pressure 34 (42.0%) 36 (58.1%) 73 (51.0%) 93 (54.1%) 60 (53.6%) 293 (51.4%) 107 (48.6%) 131 (52.8%) 47 (47.5%) 158 (52.3%) 21 (21.0%)
Diabetes 16 (19.8%) 21 (33.9%) 37 (25.9%) 47 (27.3%) 21 (18.8%) 127 (22.2%) 54 (24.5%) 71 (28.6%) 30 (30.0%) 54 (17.9%) 16 (16.0%)
Obesity 9 (45.0%) 23 (42.6%) 16 (26.7%) 47 (28.8%) 16 (22.5%) 179 (32.7%) 59 (28.5%) 40 (16.8%) 30 (41.1%) 80 (30.9%) 19 (19.2%)
Coronary Heart Disease 2 (2.50%) 5 (8.06%) 6 (4.20%) 22 (12.8%) 11 (9.82%) 67 (11.7%) 25 (11.4%) 17 (6.85%) 13 (13.0%) 26 (8.61%) 2 (2.00%)
Stroke 1 (1.23%) 3 (4.84%) 10 (6.99%) 10 (5.81%) 3 (2.68%) 44 (7.69%) 14 (6.36%) 15 (6.05%) 8 (8.00%) 24 (7.95%) 0 (0.00%)
Peripheral Arterial Disease 2 (2.47%) 1 (1.61%) 5 (3.50%) 12 (6.98%) 1 (0.89%) 29 (5.07%) 17 (7.73%) 19 (7.66%) 4 (4.00%) 9 (2.98%)
Heart Failure 0 (0.00%) 2 (3.23%) 8 (5.59%) 16 (9.30%) 10 (8.93%) 50 (8.74%) 36 (16.4%) 21 (8.47%) 9 (9.00%) 27 (8.94%) 0 (0.00%)
COPD/Asthma 8 (9.88%) 6 (9.68%) 13 (9.09%) 28 (16.3%) 25 (22.3%) 102 (17.9%) 50 (22.7%) 42 (16.9%) 17 (17.0%) 61 (20.2%) 9 (9.00%)
Chronic Liver disease 0 (0.00%) 0 (0.00%) 8 (5.59%) 8 (4.65%) 0 (0.00%) 12 (2.10%) 4 (1.82%) 10 (4.03%) 2 (2.00%) 11 (3.64%) 3 (3.00%)
Chronic Kidney disease 5 (6.17%) 2 (3.23%) 14 (9.79%) 12 (6.98%) 14 (12.5%) 57 (9.98%) 26 (11.8%) 40 (16.1%) 9 (9.00%) 32 (10.6%) 0 (0.00%)
Rheumatologic disease 4 (4.94%) 2 (3.23%) 6 (4.20%) 6 (3.51%) 4 (3.57%) 34 (5.95%) 5 (2.27%) 12 (4.84%) 1 (1.00%) 25 (8.28%) 4 (4.00%)
Cancer 11 (13.6%) 5 (8.06%) 16 (11.2%) 28 (16.3%) 17 (15.2%) 48 (8.42%) 27 (12.3%) 41 (16.5%) 7 (7.00%) 37 (12.3%) 1 (1.00%)
Clinical outcomes
Intensive Care Unit Hospitalization 9 (11.1%) 18 (29.0%) 32 (22.4%) 43 (25.0%) 1 (0.89%) 72 (12.6%) 38 (17.4%) 55 (22.2%) 11 (11.0%) 30 (9.93%) 13 (13.0%)
Fever 77 (95.1%) 55 (88.7%) 126 (88.1%) 147 (85.5%) 91 (82.0%) 446 (78.0%) 190 (86.4%) 207 (84.5%) 87 (87.9%) 251 (83.1%) 84 (84.0%)
Cough 49 (60.5%) 50 (80.6%) 108 (75.5%) 117 (68.0%) 89 (80.2%) 395 (69.2%) 127 (62.9%) 178 (72.7%) 71 (71.0%) 196 (64.9%) 67 (67.0%)
Dyspnea 25 (30.9%) 39 (62.9%) 96 (68.1%) 106 (61.6%) 80 (71.4%) 312 (54.6%) 159 (72.6%) 138 (56.3%) 67 (68.4%) 150 (49.7%) 66 (66.0%)
Bilateral alteration Thorax X ray 58 (71.6%) 52 (83.9%) 105 (73.9%) 138 (80.2%) 81 (72.3%) 362 (63.4%) 162 (73.6%) 215 (87.8%) 77 (77.0%) 224 (74.9%) 87 (87.0%)
Acute Respiratory Distress Syndrome 11 (13.6%) 14 (22.6%) 61 (43.0%) 68 (39.5%) 15 (13.4%) 122 (21.4%) 70 (31.8%) 136 (54.8%) 19 (19.2%) 77 (25.6%) 17 (17.3%)
Respiratory Failure 14 (17.3%) 10 (38.5%) 62 (43.4%) 43 (28.1%) 37 (33.0%) 73 (26.1%) 80 (37.9%) 92 (41.1%) 19 (20.2%) 65 (25.5%) 11 (22.9%)
High-Flow Mechanical Ventilation 2 (2.47%) 4 (6.45%) 12 (8.39%) 47 (27.3%) 1 (0.89%) 68 (11.9%) 62 (28.2%) 70 (28.2%) 29 (29.0%) 58 (19.3%) 17 (17.3%)
Invasive Mechanical Ventilation. Tracheal Intubation 7 (8.64%) 12 (19.4%) 25 (17.5%) 35 (20.3%) 2 (1.79%) 58 (10.1%) 36 (16.4%) 41 (16.5%) 11 (11.0%) 24 (7.97%) 11 (11.2%)
Disseminated Intravascular Coagulation 1 (1.23%) 1 (1.61%) 7 (4.93%) 5 (2.92%) 0 (0.00%) 2 (0.35%) 4 (1.82%) 9 (3.63%) 4 (4.04%) 2 (0.67%) 1 (1.02%)
Acute Renale Failure 15 (18.5%) 11 (17.7%) 29 (20.3%) 33 (19.2%) 30 (26.8%) 65 (11.4%) 36 (16.4%) 68 (27.5%) 11 (11.0%) 41 (13.6%) 2 (2.04%)
Liver alterations 2 (2.47%) 1 (1.61%) 5 (3.52%) 9 (5.23%) 1 (0.89%) 11 (1.92%) 6 (2.73%) 22 (8.91%) 5 (5.00%) 5 (1.67%) 0 (0.00%)
Shock 1 (1.23%) 5 (8.06%) 23 (16.1%) 15 (8.72%) 2 (1.79%) 18 (3.16%) 12 (5.45%) 30 (12.1%) 4 (4.00%) 22 (7.33%) 0 (0.00%)
Severity
Mild 66 (81.5%) 43 (69.4%) 90 (62.9%) 102 (59.3%) 97 (86.6%) 390 (68.2%) 133 (60.5%) 132 (53.2%) 76 (76.0%) 207 (68.5%) 81 (81.0%)
Severe 8 (9.88%) 12 (19.4%) 22 (15.4%) 39 (22.7%) 9 (8.04%) 94 (16.4%) 42 (19.1%) 41 (16.5%) 19 (19.0%) 40 (13.2%) 18 (18.0%)
Death 7 (8.64%) 7 (11.3%) 31 (21.7%) 31 (18.0%) 6 (5.36%) 88 (15.4%) 45 (20.5%) 75 (30.2%) 5 (5.00%) 55 (18.2%) 1 (1.00%)
Long-term exposure to environmental pollutants Alcover Amposta Reus Tarragona Vilafranca del Penedès Barcelona Girona Manresa Mataró Terrassa Sant Feliu de Llobregat
NO2 (µg/m3) 9.89 14.73 18.72 21.05 16.88 38.25 29.55 30.22 24.36 40.77 21.36
PM10 (µg/m3) 19.55 19.12 21.98 19.08 19.25 24.18 23.98 23.09 19.29 24.38 19.90